湖南省2008年987例严重药品不良反应病例情况分析  

987 serious adverse drug reactions in Hunan province in 2008

作　　者：龙丽萍[1] 蒋冬贵[1] 臧萍[1] 

机构地区：[1]湖南省药品审评认证与不良反应监测中心,长沙410013

出　　处：《中南药学》2009年第6期472-474,共3页Central South Pharmacy

摘　　要：目的确定今后湖南省药品不良反应监测重点,提高药品不良反应监测报告质量。方法通过使用泛珠三角不良反应监测网络平台对2008年湖南省上报国家中心的数据进行规整,使用Mcrosoft Excel软件进行统计学分析。结果湖南省2008年严重不良反应病例的药品剂型以注射剂为主,占总数的86%;静脉给药为主要用药途径,占总数的79%;抗微生物注射液和中药注射液引起的严重不良反应分别为54.7%和11.44%。结论抗微生物注射剂和中药注射剂是今后一段时间内本省药品不良反应监测的重点。Objective To determine the focus of adverse drug reaction and to improve the quality of monitoring in the future in Hunan province. Methods The adverse reaction monitoring network platform of Pan-Pearl River Delta was used to standardize the data reported to the National Center in Hunan province in 2008, and Microsoft Excel was used for statistical analysis. Results The cause of serious adverse reaction was mainly injections （86%）. Intravenous ad- ministration was the main route of administration （79%）. Anti microbial injections and Chinese medicine injections caused 54.7% and 11.44%, respectively. Conclusion Anti-microbial injections and injections of Chinese medicine in Hunan are the focus of adverse drug reaction monitoring in the future.

关 键 词：药品不良反应监测 抗微生物注射液 中药注射液 

分 类 号：R969.2[医药卫生—药理学]